Clinical Trial Update: Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating irinotecan liposome or etoposide in combination with adebrelimab and carboplatin for extensive-stage small cell lung cancer, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Irinotecan liposome (liposomal irinotecan)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: RECRUITING